IGF2BP3 and hepatocellular carcinoma: RNA pulldown assays confirmed the interaction between circRAPGEF1 and IGF2BP3 in HCC cells (Figure 3D), while RNA immunoprecipitation (RIP) assays showed that circRAPGEF1 was significantly enriched in IGF2BP3 antibody compared with IgG (Figure 3E).